期刊
CURRENT PHARMACEUTICAL DESIGN
卷 17, 期 26, 页码 2778-2786出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138161211797440168
关键词
beta-amyloid; P-glycoprotein; Alzheimer's disease; neurodegeneration; blood-brain barrier; Creutzfeldt-Jakob disease; aging
The blood-brain barrier (BBB) protects the brain against endogenous and exogenous compounds and plays an important part in the maintenance of the microenvironment of the brain. In particular, the importance of brain-to-blood transport of brain-derived metabolites across the BBB has gained increasing attention as a potential mechanism in the pathogenesis of neurodegenerative disorders such as Alzheimer's disease, which is characterized by the aberrant polymerization and accumulation of specific misfolded proteins, particularly beta-amyloid (A beta). There is growing evidence that the ABC transport protein P-glycoprotein (P-gp), a major component of the BBB, mediates the efflux of A beta from the brain. In this review, we discuss the possible role of P-gp in Alzheimer's disease and other neurodegenerative disorders, and consider how a fuller understanding of this function might promote the development of more effective treatment strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据